Two IPOs and four SPACs went public in the week of January 31, 2022 led by Arcellx Inc (NASDAQ: ACLX), a phase 1 biotech developing next-gen CAR-T therapies for blood cancers, raised $124 million at a $583 million market cap and finished 12% above its IPO price.
Phase 1-ready biotech developing in-licensed precision therapies for cancer, Nuvectis Pharma Inc (NASDAQ: NVCT) raised $16 million at a $65 million market cap and finished 35% below its IPO price.
The seven SPACs went public this past week are:
1. Kimbell Tiger Acquisition (energy and natural resources industry SPAC)
2. Murphy Canyon Acquisition (real estate industry SPAC)
3. Blue World Acquisition (marine-related businesses SPAC)
4. Alset Capital Acquisition (real estate SPAC)
Together, all the SPACs raised a total of $470 million.
#ipo #nasdaq #nyse #capitalmarket #hexcellence #spac #weeklyipo #recap
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected]